ArticleCancer immunology research2023

Microparticle-Delivered Cxcl9 Prolongs Braf Inhibitor Efficacy in Melanoma.

Gabriele Romano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.